Sarwish Rafiq

Employment

• Emory University Associate Professor
  2019 - Present
• Sloan Kettering Institute
  2012 - Present

Education

• Ohio State University PhD
  2007 - 2012

Projects & Funding

Projects & funding information is unavailable.

Publications (62)

• Modulating the VIP/VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models
  Science Translational Medicine 2026 0 citations DOI: 10.1126/scitranslmed.adt9565
  +Save
• Combination radiation and αPD-L1 enhance tumor control by stimulating CD8+PD-1+TCF-1+T cells in the tumor-draining lymph node
  NATURE COMMUNICATIONS 2025 19 citations DOI: 10.1038/S41467-025-58510-1
  +Save
• Peptide Drug-Secreting CAR T cells Targeting the VIP/VIPR Pathway Display a Novel Phenotype and Superior Antitumor Efficacy
  MOLECULAR THERAPY 2025
  +Save
• Revitalizing aged CAR T cells with anti-inflammatory cytokine IL-37
  MOLECULAR THERAPY 2025
  +Save
• Muc16CD is a novel CAR T cell target antigen for the treatment of pancreatic cancer
  Molecular Therapy: Oncology 2024 11 citations DOI: 10.1016/j.omton.2024.200868
  +Save
• Antagonizing vasoactive intestinal peptide (VIP) receptors with Muc16CD-directed armored CAR T cells for pancreatic cancer.
  JOURNAL OF CLINICAL ONCOLOGY 2024
  +Save
• Engineering Improved CAR T Cell Products with A Multi-Cytokine Particle Platform for Hematologic and Solid Tumors
  Advanced Healthcare Materials 2024 7 citations DOI: 10.1002/adhm.202302425
  +Save
• Heme Attenuates T Cell Exhaustion in Multiple Myeloma
  CLINICAL LYMPHOMA MYELOMA & LEUKEMIA 2024
  +Save
• Modulating the Vasoactive Intestinal Peptide (VIP) Pathway Reprograms Superior CAR T Cells
  BLOOD 2024 0 citations DOI: 10.1182/BLOOD-2024-208090
  +Save
• Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node
  Research Square 2024 5 citations DOI: 10.21203/rs.3.rs-3921977/v1
  +Save